We found that an increase in NEU1 expression, in addition to potentially reducing the risk of SLE, also lowers the risk of several other diseases, such as Type 1 diabetes, asthma, and diffuse diseases of connective tissue. Here, NEU1 is linked to systemic lupus erythematosus.